Global healthcare costs and demands are changing, and it’s time to look beyond mammalian cell lines.

Fighting counterfeit medicines is a noble goal, but the financial burden of safety features may affect access to medicines in unintended ways.

Interest in cannabinoid drug development is growing. The potential market – and the opportunity to treat unmet patient needs – is enormous.

Gene and Eva consider the importance of good record keeping.

A fresh take on an existing photography competition aims to display the diversity of science.

After many years of clinical trial failures in Alzheimer’s disease, pharma sees some positive results – although caution is recommended.

Finding counterfeit antibiotics – using a color-changing paper test

A recent survey examined the relationships – or lack thereof – between pharma companies and mental health patient groups

Does a medicine’s price consistently track with its benefits and value? Not in the US, according to a study.

A vaccine using mRNA demonstrates potential for broad influenza protection.